Posted on

Forest park purple seeds

Pre-rolled joints and blunts

Pre-rolled joints are ready when you are. Light, inhale, and enjoy.

Featured products

All results

Rainbow Chip Pre-Roll 1g

by Dawg Star

No stores nearby

Ripped Bubba Minigar 7g

by Washington Bud Company

No stores nearby

Island Classic Preroll: Donut Shack (Indica)

by Island

No stores nearby

Durban Poison Pre-Rolls 3g 6-pack

by Totem Farms

No stores nearby

Nova OG Pre-Roll 0.5g

by Redbarn Gardens

No stores nearby

Send Off Pre-Roll 1g

by Meraki Gardens

No stores nearby

Bubba Kush Cali Pre-Roll 1g

by HiBuddy Organics

No stores nearby

Sundae Driver Pre-Roll 0.5g

by Flowersmith

No stores nearby

Jack F1 .5G CRU x Littles Sativa Pre-Roll

by Littles

No stores nearby

CRU Glue (6 PACK) .5G CRU x Littles Hybrid Pre-Roll

by Littles

No stores nearby

Inzane In The Membrane Pre-Roll 1g

by Phat Panda by Grow Op Farms

No stores nearby

Baker’s 1g Pre-Roll – Motor Breath

by Baker’s Cannabis

No stores nearby

Ursa Major Pre-Rolls 2.5g 5-pack

by Prūf Cultivar

No stores nearby

King Louie OG .5G CRU x Littles Indica Pre-Roll

by Littles

No stores nearby

Purple Lamborghini Pre-Roll 1g

by Rev Brands

No stores nearby

9 Pound Hammer Infused Pre-roll 1g

by Decibel Farms

No stores nearby

Fruit Twist Pre-Roll 1g

by Occidental Hills

No stores nearby

GMO Zkittlez Pre-Roll 1g

by Happy Valley

No stores nearby

Get perks like local deals, new strain spotlights, and a free jar of CBD:THC gummies when you sign up ($49 value)!

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy. Offer valid for new Leafly subscribers. Available to US residents only, valid only where legal.

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.

Grandmommy Purple from Herbies Seeds is Blowing Up the Market!

Herbies Seeds is blowing up the market this year with its hot new line of cannabis seeds. One variety in particular has been taking the cannabis world by storm: Grandmommy Purple, an Indica-dominant strain that redefines relaxation.

Before digging into why Grandmommy Purple should be the next strain on your grow list, let’s talk about Herbies Seeds. Already a well-established seed retailer in the cannabis market, Herbies has cracked the code of what a modern grower wants:

  • Herbies website is user-oriented, with sleek design and simple order placement process (registration is not necessary).
  • It sends seeds worldwide and offers several payment and shipment options, including safe stealth shipping.
  • All buyers get to benefit from 24/7 customer support and nice bonuses added to all orders, including free seeds.

Herbies has been making waves this year after branching out into producing its own potent and tasty genetics. The company has applied knowledge of weed consumers’ needs by teaming up with Spanish breeders to pump out a new line of seeds last May and another one later in August. Don’t worry, you’ll get an introduction to all of the Herbies’ different strains later in this article.

All About Grandmommy Purple

Herbies’ newly-released Grandmommy Purple is already a hit among customers—over the last few months, the seeds have rapidly risen to stardom as the currently best-selling variety in the Herbies store. What makes this strain so prolific, you might ask?

Spanish breeders have put their heads together to create a new phenotype from parents Big Bud and Purple Urkle. Truly a powerful combination, the resulting Grandmommy Purple is an Indica-dominant (80 percent) hybrid with skyscraping potency ranging from 28 to 33 percent THC—a level that very few strains in the world reach.

It might just be love at first sight—your eyes won’t know what to focus on first! The buds are a light to emerald green accented with a healthy dusting of sparkling trichomes and bright orange hairs. The sugar-topped leaves, tinged with reddish-purple tones reminiscent of fall, complete the bouquet.

These Grandmommy Purple seeds were made for growers searching for a no-fuss strain. Feminized to guarantee that seedlings will grow up to be female, the seeds mature into small plants indicative of their Indica genetics. Growing to a maximum average height of 40 to 140cm (15.5 to 55 inches), commercial and hobby growers alike will be pleased with these ladies’ yields of 500g/m 2 (1.6oz/ft 2 ) indoors and up to 550g (19.4oz) per plant outdoors. In just 60 to 65 days of flowering, you’ll be graced with dense, sticky nugs of beautiful cannabis.

Sure, Grandmommy Purple’s not the biggest plant on the block, but this is one of those situations where size doesn’t matter. As we mentioned earlier, the 28 to 33 percent THC content of this strain is truly out of this world, and that’s what makes her the star of the show. The buds that grow from this Herbies strain are dense and sticky with resin—amazing rolled up to smoke, but even better when set aside for vaporizing or making concentrates.

Even though Grandmommy Purple was released not that long ago, the reviews on the first grown and harvested plants keep coming in. On Growdiaries, one reviewer says “She is looking amazing… such wonderful strain to work with,” while another grower adds, “In flower, she showed awesome pink/dark purple colors and a great scent. Buds were dense and stuffed with trichomes. Just perfect for me. Pictures can’t show her real beauty. From me, 10 out of 10.”

After putting in the hard work and patience of growing, harvesting, drying and curing… it’s time to enjoy some Grandmommy Purple! Combustion introduces a pungent scent highlighted by a mellow sweetness, like wild berries harvested from the forest. Her fruity terpene profile is also evident in the flavors of the smoke—a sweet respite tasting of fruity hard candies. With each puff, you’ll feel like you’re dipping your hands into the bowl of sweets in Grandma’s living room.

It won’t be long before the effects of Grandmommy Purple start to envelop you like a handmade quilted blanket. Her Indica-heavy ancestry makes for a clear-headed euphoric experience punctuated by deep-seated relaxation. Ready to cuddle under the blankets on the couch watching a movie? Or are you simply ready to crawl into bed? Whatever your weekend chill-out plans are, Grandmommy Purple’s elevated entourage effect will always achieve the perfect state of medicated relaxation.

See also  Australian bastard cannabis seeds canada

Without a doubt, Herbies Seeds has knocked it out of the park with this strain!

Grandmommy Purple is a wonderful addition to any cannabis enthusiast’s seed collection, and is only one of the reasons why you should turn to Herbies Seeds for the hottest new strains.

Why You Should Check Out Herbies

What else does Herbies Seeds have to offer? Aside from a massive catalog of thousands of cannabis strains from seed banks all around the world, Herbies’ very own seed bank has been gaining traction since its release earlier this year. Their branded strains are already being actively discussed online—fans of Herbies are sharing their successes on social platforms like Reddit and Growdiaries, where strains from Herbies seeds have already surpassed 30 diaries with an average strain score of 9.5 out of 10!

The selection is extremely well-rounded—there’s a strain here for everyone —photoperiods and autoflowers, genetics with high THC levels and fruity terpene profiles, the ones for buds drowning in resin or for branches heavy with rock-solid flowers, you name it!

Herbies Seeds is turning heads with all of these fantastic new cannabis seed varieties, especially because they cater to the needs of home growers everywhere. What better way to find your next favorite strain than to grab a Herbies Seeds mix pack and decide for yourself? They’ve certainly proved themselves as a seed bank that won’t disappoint. If you don’t know what to start from in exploring Herbies’ line of seeds, we also recommend giving a try to Godzilla Cookies Auto, an autoflower with large yields of 27 percent THC bud, or mood-enhancing, orange-flavored 30 percent THC Mimosa Shot.

What Are You Waiting For?

The launch of Herbies’ very own seed bank has been incredibly exciting news for growers of all skill levels. It’s almost impossible to choose a favorite strain from Herbies… almost. It’s hard not to fall in love with Grandmommy Purple—a strain that’s incredibly potent while somehow also as sweet as pie. You might find yourself torn between keeping the buds whole for their gorgeous bag appeal or taking advantage of all that sticky resin for ultra- potent concentrate.

Any way you swing it, Herbies Seeds is already proving to be a producer of quality cannabis seed varieties. It seems there’s only one way to go from here: higher and higher! Check out the Herbies website for an extensive catalog of all things cannabis seeds. Trust us, your garden will thank you.

Analysts cut hundreds of millions from Tilray, Canopy, Aurora marijuana sales forecasts

Cannabis Banking Defeat In Congress Opens Opportunity For Equity-Centered Approach (Op-Ed)

You may like

Leave a Reply Cancel reply

High Life

Missouri House Committee Approves Joint Resolution To Put Marijuana Legalization On The Ballot

A Missouri House committee on Tuesday approved a GOP-led joint resolution seeking to place the issue of marijuana legalization before voters on the November ballot.

The Special Committee on Criminal Justice passed an amended version of the legislation, sponsored by the panel’s chairman Rep. Shamed Dogan (R), in a 7-2 vote.

The development comes amid a push for separate measure to enact legalization legislatively that’s also advanced through committee but ran up against procedural hurdles on the House floor this week.

While Dogan’s measure has now moved through his committee, an activist-and industry-led campaign is still pursuing its own separate initiative to put legalization on the ballot this November.

Certain advocates and stakeholders have expressed concerns about that campaign’s initiative, voicing preference for a reform bill sponsored by Rep. Ron Hicks (R). It’s unclear when that measure might be taken up on the floor, as the sponsor was recently told by leadership that it wasn’t ready to move.

Dogan, for his part, pre-filed his joint resolution to place a constitutional amendment on legalization on the 2022 ballot late last year. He introduced a similar proposal last year, but it did not advance.

Under the lawmaker’s plan as amended by the panel on Tuesday, cannabis offenses would be removed from the state’s criminal statute, allowing adults to possess, use and sell marijuana for personal use without facing penalties, pending future regulations that could be enacted by the legislature.

The committee substitute that the panel adopted changes the original proposal by omitting provisions that would have eliminated the state’s existing separate medical cannabis program and set policies related to taxation in the adult-use market.

Dogan said that the substitute “streamlines the original resolution,” proposing a simple policy change that voters would decide on while leaving further regulations on the legal market for the legislature to decide at a later point.

Originally, his measure included language on taxing marijuana sales, distributing tax revenue, employer rights and more. The chairman said that he wanted the body to pass the amended version as a “straightforward” alternative to the initial resolution.

Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

If enacted as drafted, no police or state funds could have been used to assist in the enforcement of federal cannabis prohibition. And the state couldn’t have allowed asset or civil forfeiture for citizens of age who conducted marijuana activities made lawful under the measure.

The intent of the committee substitute, Dogan said, is to empower the legislature to craft regulations if voters decide to approve a legalization question on the ballot.

The measure no longer includes “caps and [licensing policies] and all that stuff,” he said. “The legislature could say, ‘you know, we’re going to have people operate [a marijuana business] within 20 feet of a school zone or not,’ or the legislature can say, ‘you can have 10 licenses or you can have 20. That’s left up to future legislatures.”

See also  Connoisseur cannabis seeds

The effective date of the resolution is January 31, 2024, giving lawmakers more than a year to craft regulations if the proposal makes it to the ballot and is then approved by voters.

Meanwhile, if advocates want to get legalization enacted through the legislature this session, there’s little time left to spare. The Hicks bill is expected to reach the floor imminently, but the session ends on May 13.

Hicks recently said that the timeline remains feasible and he’s “seen bills sail through the process in a week.” The lawmaker said that it “really comes down to whether we have the will to tackle it.”

The bill he’s proposing would legalize the possession and sale of cannabis for adults 21 or older, provide opportunities for expungements, authorize social consumption facilities and permit cannabis businesses to claim tax deductions with the state.

Advocates wanted to see the bill move through the committee process without revisions to the introduced legislation, but members did end up adopting several amendments in the first committee stop.

Another Republican lawmaker in the state, Rep. Jason Chipman (R), filed a joint resolution this session that would let voters require additional oversight over how medical cannabis tax revenue is distributed to veterans.

Meanwhile, the group New Approach Missouri, which successfully got a medical cannabis initiative passed by voters in 2018, announced last summer its plans to put the reform proposal on the ballot through its new campaign committee Legal Missouri 2022. The signature turn-in deadline for ballot initiatives this year is May 8.

The organization tried to place the issue of legalization before voters in 2020, but the COVID-19 pandemic derailed that effort.

Despite the health crisis, activists managed to collect tens of thousands of raw signatures within months, though they needed 160,199 valid signatures to qualify.

A different campaign, Fair Access Missouri, separately explored multiple citizen initiatives this year with the hopes of getting at least one on the ballot.

Another state lawmaker filed a bill late in February to decriminalize a range of drugs including marijuana, psilocybin, LSD, MDMA and cocaine.

The measure’s introduction came after a Republican Missouri legislator filed a separate bill to give residents with serious illnesses legal access to a range of psychedelic drugs like psilocybin, ibogaine and LSD through an expanded version of the state’s existing right-to-try law.

Additionally, a Missouri House committee held a hearing in March on a GOP-led bill to legalize a wide range of psychedelics for therapeutic use at designated care facilities while further decriminalizing low-level possession in general.

Nearly one out of every 10 jobs that were created in Missouri last year came from the state’s medical marijuana industry, according to an analysis of state labor data that was released by a trade group last month.

Separately, there’s some legislative drama playing out in the state over a proposal that advocates say would restrict their ability to place Constitutional amendments on the ballot.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

High Life

Connecticut House Approves Psychedelic Treatment Program As Part Of Budget Bill

The Connecticut House of Representatives on Monday approved a large-scale budget bill that includes provisions to set the state up to provide certain patients with access to psychedelic-assisted treatment using substances like MDMA and psilocybin.

The language largely mirrors a standalone bill that moved through committee earlier this session. However, the budget legislation is more limited with respect to who would be eligible for the treatment option compared to the standalone proposal.

The budget measure is expected to go to the Senate for consideration as early as Tuesday, after which point it could be sent to the governor if no amendments are made.

Under both the budget bill and HB 5396, psychedelic treatment centers would be established in the state where people could receive psilocybin-assisted or MDMA-assisted therapy as part of an expanded access program for investigational new drugs through the federal Food and Drug Administration (FDA).

While the legislation would not legalize the psychedelics, it would set up a regulatory infrastructure to enable Connecticut to play a leading role in providing access to this alternative treatment option as federal agencies continue to fund and facilitate clinical trials.

Psychedelic therapy would be specifically provided and funded for military veterans, retired first responders and health care workers under the budget measure.

The standalone bill, meanwhile, was more expansive by also including any person from a “historically underserved community, and who has a serious or life-threatening mental or behavioral health disorder and without access to effective mental or behavioral health medication.”

Gov. Ned Lamont (D) signed a separate bill last year that includes language requiring the state to carry out a study into the therapeutic potential of psilocybin mushrooms. A workgroup has since been meeting to investigate the issue.

Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

The new House-passed budget measure and standalone bill, meanwhile, would require the state Department of Mental Health and Addiction Services to launch a “psychedelic-assisted therapy pilot program to provide qualified patients with the funding” to receive MDMA or psilocybin therapy as part of FDA’s expanded access program.

The pilot program would cease “when MDMA and psilocybin have been approved to have a medical use by the Drug Enforcement Administration (DEA), or any successor agency.” At that point, state statute on the substances would be aligned with the federal government’s.

The legislation would further establish a Qualified Patients for Approved Treatment Sites Fund to provide “grants to qualified applicants to provide MDMA-assisted or psilocybin assisted therapy to qualified patients under the pilot program.”

Another difference between the newly passed budget measure and the earlier standalone bill is that the latter called for $3 million to be appropriated to the Department of Mental Health and Addiction Services from the general fund to facilitate the treatment centers, whereas the former simply provides funding “within available appropriations.”

See also  Josh d og seeds

Both measures would further create a Connecticut Psychedelic Treatment Advisory Board under the department. Legislative leaders and the governor would be empowered to appoint members of the board.

The board would be tasked with making recommendation on the “design and development of the regulations and infrastructure necessary to safely allow for therapeutic access to psychedelic-assisted therapy upon the legalization of MDMA, psilocybin and any other psychedelic compounds.”

There would be seven key areas that the board would be responsible for advising the department on:

  1. Reviewing and considering the data from the psychedelic-assisted therapy pilot program…to inform the development of such regulations
  2. Advising the department on the necessary education, training, licensing and credentialing of therapists and facilitators, patient safety, harm reduction, the establishment of equity measures in both clinical and therapeutic settings, cost and insurance reimbursement considerations and standards of treatment facilities
  3. Advising the department on the use of group therapy and other therapy options to reduce cost and maximize public health benefits from psychedelic treatments
  4. Monitoring updated federal regulations and guidelines for referral and consideration by the state agencies of cognizance for implementation of such regulations and guidelines.
  5. Developing a long-term strategic plan to improve mental health care through the use of psychedelic treatment.
  6. Recommending equity measures for clinical subject recruitment and facilitator training recruitment
  7. Assisting with the development of public awareness and education campaigns.

Meanwhile, the state’s Social Equity Council approved a list of geographic areas disproportionately impacted by the drug war, which will be used to determine eligibility for social equity business licenses. Under the state’s new cannabis program, half of all licenses must go to equity applicants, who may also qualify for lower licensing fees, technical assistance, workforce training and funding to cover startup costs.

Last year, Lamont also announced the launch of a new website to provide residents with up-to-date information on the state’s new marijuana legalization law.

As it stands, adults 21 and older are already able to possess up to 1.5 ounces of cannabis for personal use.

In the psychedelics space, reform is advancing in states across the country.

For example, the Colorado Senate approved a House-passed bill last week to align state statute to legalize MDMA prescriptions if and when the federal government ultimately permits such use, sending the measure to the governor.

Maryland lawmakers recently sent a bill to the governor that would create a state fund to provide “cost-free” access to psychedelics like psilocybin, MDMA and ketamine for military veterans suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury.

The Maine Senate approved a bill last month to to create a medical psilocybin program in the state, but the House of Representatives refused to go along.

Also last month, Georgia lawmakers advanced a bipartisan resolution that calls for the formation of a House study committee to investigate the therapeutic potential of psychedelics like psilocybin and make recommendations for reforms.

The governor of Utah signed a bill in March to create a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations for their lawful use.

A Missouri House committee also held a hearing that month on a GOP-led bill to legalize a wide range of psychedelics for therapeutic use at designated care facilities while further decriminalizing low-level possession in general.

The Washington State legislature recently sent a budget bill to the governor’s desk that includes a proposal to direct $200,000 in funding to support a new workgroup to study the possibility of legalizing psilocybin services in the state, including the idea of using current marijuana regulatory systems to track psychedelic mushrooms.

In March, the Hawaii Senate approved a bill to set up a state working group to study the therapeutic benefits of psilocybin mushrooms and develop a “long-term” plan to ensure that the psychedelic is accessible for medical use for adults 21 and older.

Also that month, the Oklahoma House of Representatives passed a bill to decriminalize low-level possession of psilocybin and promote research into the therapeutic potential of the psychedelic.

Rhode Island lawmakers introduced a pair of drug decriminalization bills in March—including one focused on psilocybin and buprenorphine that would authorize doctors to prescribe the psychedelic mushroom.

An Oregon Senate committee also recently advanced a bill to ensure that equity is built into the state’s historic therapeutic psilocybin program that’s actively being implemented following voter approval in 2020.

A bill to decriminalize a wide array of psychedelics in Virginia was taken up by a House of Delegates panel in January, only to be pushed off until 2023. A separate Senate proposal to decriminalize psilocybin alone was later defeated in a key committee.

California Sen. Scott Wiener (D) told Marijuana Moment in a recent interview that his bill to legalize psychedelics possession stands a 50/50 chance of reaching the governor’s desk this year. It already cleared the full Senate and two Assembly committees during the first half of the two-year session.

Washington State lawmakers also introduced legislation in January that would legalize what the bill calls “supported psilocybin experiences” by adults 21 and older.

Meanwhile, a Pennsylvania bill meant to promote research into the therapeutic potential of psilocybin mushrooms for certain mental health conditions may be in jeopardy, with the sponsor saying that the chair of a key House committee is expressing reservations even after the legislation was amended in an effort to build support.

New Hampshire lawmakers filed measures to decriminalize psilocybin and all drugs.

Legislation was also enacted by the Texas legislature last year requiring the state to study the medical risks and benefits of psilocybin, MDMA and ketamine for military veterans in partnership with Baylor College of Medicine and a military-focused medical center.

At the congressional level, bipartisan lawmakers sent a letter to DEA in January, urging that the agency allow terminally ill patients to use psilocybin as an investigational treatment without the fear of federal prosecution.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.